DELPHX CAPITAL MARKETS INC (DELX.CA) Stock Fundamental Analysis

TSX-V:DELX • CA24721L1013

0.045 CAD
0 (0%)
Last: Feb 20, 2026, 07:00 PM
Fundamental Rating

0

Taking everything into account, DELX scores 0 out of 10 in our fundamental rating. DELX was compared to 79 industry peers in the Capital Markets industry. Both the profitability and financial health of DELX have multiple concerns. DELX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year DELX has reported negative net income.
  • In the past year DELX has reported a negative cash flow from operations.
  • In the past 5 years DELX always reported negative net income.
  • In the past 5 years DELX always reported negative operating cash flow.
DELX.CA Yearly Net Income VS EBIT VS OCF VS FCFDELX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

  • DELX has a Return On Assets of -1753.95%. This is amonst the worse of the industry: DELX underperforms 93.67% of its industry peers.
Industry RankSector Rank
ROA -1753.95%
ROE N/A
ROIC N/A
ROA(3y)-1603.25%
ROA(5y)-1093.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DELX.CA Yearly ROA, ROE, ROICDELX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K -2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for DELX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DELX.CA Yearly Profit, Operating, Gross MarginsDELX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024

0

2. Health

2.1 Basic Checks

  • DELX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for DELX has been increased compared to 5 years ago.
  • There is no outstanding debt for DELX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DELX.CA Yearly Shares OutstandingDELX.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
DELX.CA Yearly Total Debt VS Total AssetsDELX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

2.2 Solvency

  • DELX has an Altman-Z score of -419.29. This is a bad value and indicates that DELX is not financially healthy and even has some risk of bankruptcy.
  • DELX has a Altman-Z score of -419.29. This is amonst the worse of the industry: DELX underperforms 87.34% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -419.29
ROIC/WACCN/A
WACCN/A
DELX.CA Yearly LT Debt VS Equity VS FCFDELX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M

2.3 Liquidity

  • A Current Ratio of 0.06 indicates that DELX may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.06, DELX is doing worse than 91.14% of the companies in the same industry.
  • A Quick Ratio of 0.06 indicates that DELX may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.06, DELX is not doing good in the industry: 91.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
DELX.CA Yearly Current Assets VS Current LiabilitesDELX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 40.64% over the past year.
EPS 1Y (TTM)40.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DELX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DELX.CA Price Earnings VS Forward Price EarningsDELX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DELX.CA Per share dataDELX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0 -0.01 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for DELX!.
Industry RankSector Rank
Dividend Yield 0%

DELPHX CAPITAL MARKETS INC

TSX-V:DELX (2/20/2026, 7:00:00 PM)

0.045

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)12-01
Earnings (Next)N/A
Inst Owners14.04%
Inst Owner ChangeN/A
Ins Owners7.74%
Ins Owner ChangeN/A
Market Cap9.81M
Revenue(TTM)N/A
Net Income(TTM)-2.73M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1753.95%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1603.25%
ROA(5y)-1093.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -419.29
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.03%
OCF growth 3YN/A
OCF growth 5YN/A

DELPHX CAPITAL MARKETS INC / DELX.CA FAQ

Can you provide the ChartMill fundamental rating for DELPHX CAPITAL MARKETS INC?

ChartMill assigns a fundamental rating of 0 / 10 to DELX.CA.


Can you provide the valuation status for DELPHX CAPITAL MARKETS INC?

ChartMill assigns a valuation rating of 0 / 10 to DELPHX CAPITAL MARKETS INC (DELX.CA). This can be considered as Overvalued.


Can you provide the profitability details for DELPHX CAPITAL MARKETS INC?

DELPHX CAPITAL MARKETS INC (DELX.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for DELX stock?

The financial health rating of DELPHX CAPITAL MARKETS INC (DELX.CA) is 0 / 10.